Empagliflozin protects against renal ischemia/reperfusion injury in mice

Renal ischemia/reperfusion (I/R) can induce acute kidney injury. Empagliflozin is a newly developed inhibitor of sodium-glucose cotransporter-2 (SGLT2) approved as an antidiabetic medication for patients with type 2 diabetes mellitus. Despite the established cardioprotective functions of empaglifloz...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qifeng, Ju, Feng, Li, Jiaxue, Liu, Ting, Zuo, Yunxia, Abbott, Geoffrey W., Hu, Zhaoyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652474/
https://www.ncbi.nlm.nih.gov/pubmed/36369319
http://dx.doi.org/10.1038/s41598-022-24103-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652474/
https://www.ncbi.nlm.nih.gov/pubmed/36369319
http://dx.doi.org/10.1038/s41598-022-24103-x

Ejemplares similares